<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zou Z</submitter><funding>NHLBI NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>986-994</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11499264</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>634(8035)</volume><pubmed_abstract>Mutation of tet methylcytosine dioxygenase 2 (encoded by TET2) drives myeloid malignancy initiation and progression&lt;sup>1-3&lt;/sup>. TET2 deficiency is known to cause a globally opened chromatin state and activation of genes contributing to aberrant haematopoietic stem cell self-renewal&lt;sup>4,5&lt;/sup>. However, the open chromatin observed in TET2-deficient mouse embryonic stem cells, leukaemic cells and haematopoietic stem and progenitor cells&lt;sup>5&lt;/sup> is inconsistent with the designated role of DNA 5-methylcytosine oxidation of TET2. Here we show that chromatin-associated retrotransposon RNA 5-methylcytosine (m&lt;sup>5&lt;/sup>C) can be recognized by the methyl-CpG-binding-domain protein MBD6, which guides deubiquitination of nearby monoubiquitinated Lys119 of histone H2A (H2AK119ub) to promot</pubmed_abstract><journal>Nature</journal><pubmed_title>RNA m&amp;lt;sup&amp;gt;5&amp;lt;/sup&amp;gt;C oxidation by TET2 regulates chromatin state and leukaemogenesis.</pubmed_title><pmcid>PMC11499264</pmcid><funding_grant_id>R01 HL145883</funding_grant_id><funding_grant_id>R01 HL146664</funding_grant_id><funding_grant_id>R01 CA285299</funding_grant_id><funding_grant_id>R01 HL174477</funding_grant_id><funding_grant_id>RM1 HG008935</funding_grant_id><pubmed_authors>Gao B</pubmed_authors><pubmed_authors>He C</pubmed_authors><pubmed_authors>Xu M</pubmed_authors><pubmed_authors>Hong J</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Dou X</pubmed_authors><pubmed_authors>Zou Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yang FC</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Dai Q</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Yu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA m&amp;lt;sup&amp;gt;5&amp;lt;/sup&amp;gt;C oxidation by TET2 regulates chromatin state and leukaemogenesis.</name><description>Mutation of tet methylcytosine dioxygenase 2 (encoded by TET2) drives myeloid malignancy initiation and progression&lt;sup>1-3&lt;/sup>. TET2 deficiency is known to cause a globally opened chromatin state and activation of genes contributing to aberrant haematopoietic stem cell self-renewal&lt;sup>4,5&lt;/sup>. However, the open chromatin observed in TET2-deficient mouse embryonic stem cells, leukaemic cells and haematopoietic stem and progenitor cells&lt;sup>5&lt;/sup> is inconsistent with the designated role of DNA 5-methylcytosine oxidation of TET2. Here we show that chromatin-associated retrotransposon RNA 5-methylcytosine (m&lt;sup>5&lt;/sup>C) can be recognized by the methyl-CpG-binding-domain protein MBD6, which guides deubiquitination of nearby monoubiquitinated Lys119 of histone H2A (H2AK119ub) to promot</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T08:04:06.719Z</modification><creation>2025-04-04T23:32:25.855Z</creation></dates><accession>S-EPMC11499264</accession><cross_references><pubmed>39358506</pubmed><doi>10.1038/s41586-024-07969-x</doi></cross_references></HashMap>